Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CTCX Carmell	$2.54 +0.8%	$2.93	$0.17 ▼ $1.27	$53.10M	0.51	4.65 million shs	29,302 shs
RBOT Vicarious Surgical	$6.69 +4.8%	$8.57	$5.00 ▼ $19.00	$39.97M	1.41	39,388 shs	40,280 shs
SPAI Safe Pro Group	$5.69 +12.2%	$3.40	$1.47 ▼ $6.50	$81.97M	N/A	370,787 shs	471,301 shs
XAIR Beyond Air	$2.25 +9.2%	$3.26	$2.02 ▼ $13.52	$10.77M	0.25	198,181 shs	94,882 shs

The 10 Best AI Stocks to Own in 2025

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CTCX Carmell	+0.79%	+8.09%	-38.94%	+6.72%	+262.86%
RBOT Vicarious Surgical	+4.21%	-1.69%	-44.48%	+0.15%	-3.81%
SPAI Safe Pro Group	+12.23%	+48.18%	+48.56%	+99.65%	+568,999,900.00%
XAIR Beyond Air	+9.22%	-3.02%	-33.04%	-40.79%	-75.68%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CTCX Carmell	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RBOT Vicarious Surgical	0.815 of 5 stars	1.0	2.0	0.0	0.0	2.3	2.5	0.6
SPAI Safe Pro Group	0.8197 of 5 stars	2.0	0.0	0.0	0.0	2.3	1.7	0.0
XAIR Beyond Air	3.8333 of 5 stars	3.8	2.0	0.0	3.5	1.9	0.8	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CTCX Carmell	0.00	N/A	N/A	N/A
RBOT Vicarious Surgical	2.00	Hold	$7.00	4.71% Upside
SPAI Safe Pro Group	4.00	Strong Buy	$8.00	40.60% Upside
XAIR Beyond Air	3.50	Strong Buy	$11.00	388.89% Upside

Current Analyst Ratings Breakdown

Latest XAIR, SPAI, CTCX, and RBOT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/21/2025	XAIR Beyond Air	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$11.00
8/13/2025	RBOT Vicarious Surgical	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$8.50 ➝ $7.00
8/13/2025	XAIR Beyond Air	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$11.00
7/17/2025	SPAI Safe Pro Group	Litchfield Hills Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy	$8.00
7/17/2025	XAIR Beyond Air	D Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
7/17/2025	XAIR Beyond Air	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$11.00

(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CTCX Carmell	$32.84K	1,616.94	N/A	N/A	$1.07 per share	2.37
RBOT Vicarious Surgical	N/A	N/A	N/A	N/A	$3.89 per share	N/A
SPAI Safe Pro Group	$2.17M	42.40	N/A	N/A	$0.16 per share	35.56
XAIR Beyond Air	$3.70M	3.18	N/A	N/A	$1.99 per share	1.13

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CTCX Carmell	-$15.44M	N/A	0.00	∞	N/A	N/A	-217.50%	-50.22%	N/A
RBOT Vicarious Surgical	-$63.22M	-$10.09	N/A	N/A	N/A	N/A	-148.14%	-98.07%	11/11/2025 (Estimated)
SPAI Safe Pro Group	-$7.43M	-$0.80	N/A	∞	N/A	-731.46%	-328.85%	-248.09%	9/25/2025 (Estimated)
XAIR Beyond Air	-$46.62M	-$11.93	N/A	N/A	N/A	-880.72%	-232.61%	-115.92%	11/10/2025 (Estimated)

Latest XAIR, SPAI, CTCX, and RBOT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	SPAI Safe Pro Group	N/A	-$0.13	N/A	-$0.13	N/A	$0.09 million
8/12/2025	Q2 2025	RBOT Vicarious Surgical	-$2.61	-$2.23	+$0.38	-$2.23	N/A	N/A
8/12/2025	Q1 2026	XAIR Beyond Air	-$1.50	-$1.53	-$0.03	-$1.53	$1.75 million	$1.76 million
6/17/2025	Q4 2025	XAIR Beyond Air	-$2.80	-$1.80	+$1.00	-$0.09	$1.39 million	$1.15 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CTCX Carmell	N/A	N/A	N/A	N/A	N/A
RBOT Vicarious Surgical	N/A	N/A	N/A	N/A	N/A
SPAI Safe Pro Group	N/A	N/A	N/A	N/A	N/A
XAIR Beyond Air	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CTCX Carmell	N/A	0.31	0.29
RBOT Vicarious Surgical	N/A	5.11	5.11
SPAI Safe Pro Group	0.06	1.64	1.34
XAIR Beyond Air	0.92	3.24	2.71

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CTCX Carmell	24.22%
RBOT Vicarious Surgical	47.27%
SPAI Safe Pro Group	N/A
XAIR Beyond Air	31.50%

Insider Ownership

Company	Insider Ownership
CTCX Carmell	29.00%
RBOT Vicarious Surgical	11.99%
SPAI Safe Pro Group	54.80%
XAIR Beyond Air	19.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CTCX Carmell	14	20.91 million	14.84 million	Not Optionable
RBOT Vicarious Surgical	210	5.93 million	5.22 million	No Data
SPAI Safe Pro Group	11	16.17 million	7.31 million	N/A
XAIR Beyond Air	70	5.23 million	4.21 million	Optionable

XAIR, SPAI, CTCX, and RBOT Headlines

Recent News About These Companies

Beyond Air (NASDAQ:XAIR) Earns Buy Rating from D. Boral Capital

August 22 at 3:25 AM | americanbankingnews.com

Beyond Air, Inc. (NASDAQ:XAIR) Short Interest Update

August 22 at 2:42 AM | americanbankingnews.com

Beyond Air, Inc. Expands Global LungFit® PH Distribution Network to 34 Countries

August 20 at 8:51 AM | quiverquant.comQ

Beyond Air Signs New International LungFit PH® Distribution Agreements, Most Notably in Japan

August 20 at 8:00 AM | globenewswire.com

Beyond Air (NASDAQ:XAIR) Lowered to Sell Rating by Wall Street Zen

August 18, 2025 | americanbankingnews.com

D. Boral Capital Reiterates "Buy" Rating for Beyond Air (NASDAQ:XAIR)

August 15, 2025 | americanbankingnews.com

Beyond Air price target lowered to $5 from $20 at Piper Sandler

August 14, 2025 | msn.com

Beyond Air’s Earnings Call Highlights Growth and Challenges

August 13, 2025 | msn.com

Beyond Air, Inc. (NASDAQ:XAIR) Q1 2026 Earnings Call Transcript

August 13, 2025 | msn.com

Beyond Air Reports Strong Revenue Growth in Q1 2026

August 13, 2025 | msn.com

Beyond Air reports Q1 EPS ($1.53) vs. ($5.32) last year

August 12, 2025 | msn.com

Beyond Air, Inc. (XAIR) Q1 2026 Earnings Call Transcript

August 12, 2025 | seekingalpha.com

Beyond Air, Inc. (XAIR) Reports Q1 Loss, Lags Revenue Estimates

August 12, 2025 | zacks.com

Beyond Air Inc (XAIR) Q1 2026 Earnings Report Preview: What To Expect

August 12, 2025 | finance.yahoo.com

Beyond Air Schedules First Fiscal Quarter 2026 Financial Results Conference Call and Webcast

July 25, 2025 | globenewswire.com

Beyond Air stock surges after securing Premier group purchasing deal

July 22, 2025 | in.investing.com

Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc.

July 22, 2025 | globenewswire.com

XAIR | Beyond Air Inc. Annual Cash Flow Statement | MarketWatch

July 19, 2025 | marketwatch.com

D. Boral Capital Initiates Coverage of Beyond Air (XAIR) with Buy Recommendation

July 18, 2025 | msn.com

Beyond Air, Inc. (XAIR) - Yahoo Finance

July 12, 2025 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

XAIR, SPAI, CTCX, and RBOT Company Descriptions

Carmell NASDAQ:CTCX

$2.54 +0.02 (+0.79%)

As of 08/21/2025

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.

Vicarious Surgical NYSE:RBOT

$6.68 +0.31 (+4.78%)

Closing price 08/22/2025 03:58 PM Eastern

Extended Trading

$6.74 +0.05 (+0.75%)

As of 08/22/2025 07:37 PM Eastern

Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Safe Pro Group NASDAQ:SPAI

$5.69 +0.62 (+12.23%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$5.82 +0.13 (+2.20%)

As of 08/22/2025 07:57 PM Eastern

Safe Pro Group, Inc. engages in the provision and acquisition of security and protection products. Its products include Artificial Intelligence (AI) and Machine Learning (ML) software technology and photogrammetry analysis tools, bullet and blast resistant personal protection equipment, and aerial managed services and mission-critical uncrewed solutions. The firm operates through the following segments: Safe-PRO USA, Airborne Response, and Safe Pro AI. The company was founded by Daniyel Erdberg on December 15, 2021 and is headquartered in Aventura, FL.

Beyond Air NASDAQ:XAIR

$2.25 +0.19 (+9.22%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$2.24 -0.02 (-0.67%)

As of 08/22/2025 06:05 PM Eastern

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time